WI
CLB icon

Wintrust Investments’s Core Laboratories CLB Stock Holding History

Wintrust Investments’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$175K Sell
10,142
-30,679
-75% -$592K 0.15% 112
2024
Q3 		$762K Sell
40,821
-366,590
-90% -$7.36M 0.56% 33
2024
Q2 		$8.3M Sell
407,411
-13,000
-3% -$230K 0.68% 30
2024
Q1 		$7.18M Buy
420,411
+145,161
+53% +$2.28M 0.63% 30
2023
Q4 		$4.86M Sell
275,250
-8,399
-3% -$169K 0.47% 38
2023
Q3 		$6.81M Sell
283,649
-70,600
-20% -$1.73M 0.71% 27
2023
Q2 		$8.24M Buy
+354,249
New +$8.01M 0.83% 24
2023
Q1 		– Sell
-399,342
Closed -$8.1M – 341
2022
Q4 		$8.1M Buy
399,342
+33,507
+9% +$649K 1.06% 15
2022
Q3 		$4.93M Buy
365,835
+174,811
+92% +$2.95M 0.62% 32
2022
Q2 		$3.78M Buy
191,024
+183,239
+2,354% +$4.87M 0.45% 43
2022
Q1 		$246K Buy
+7,785
New +$218K 0.02% 353

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wintrust Investments's CLB Position: Q4 2024 in Review

Wintrust Investments reduced its Core Laboratories (CLB) stake by 75% in Q4 2024, selling an estimated $592K and leaving 10,142 shares worth $175K. The position accounts for 0.15% of the portfolio, ranked #112.

Wintrust Investments first reported a position in CLB in Q1 2022 and has held it in 11 quarters since. The position peaked at $8.3M in Q2 2024. 209 funds tracked by Wall St. Rank hold CLB as of Q4 2024.

  • Wintrust Investments held 10,142 shares of Core Laboratories worth $175K as of Q4 2024.
  • Wintrust Investments sold 30,679 Core Laboratories shares in Q4 2024, an estimated $592K.
  • Core Laboratories made up 0.15% of Wintrust Investments's portfolio in Q4 2024, its #112 holding.
  • Wintrust Investments first reported a position in Core Laboratories in Q1 2022 and has held it in 11 quarters since.
  • Wintrust Investments's Core Laboratories position peaked at $8.3M in Q2 2024.
  • 209 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.